ISR offers free data points from “MSL and Sales Strategies for the US Oncology Market“, including an examination of manufacturers’ current level of access to Oncologists, the relationships Oncologists view as valuable, and type of drug information Oncologists prefer from peer-based literature and eDetailing sessions.
View File